Secorapamycin B

For research use only. Not for therapeutic Use.

  • CAT Number: C001129
  • CAS Number: 185107-79-3
  • Molecular Formula: C₅₁H₈₁NO₁₄
  • Molecular Weight: 932.19
  • Purity: ≥95%
Inquiry Now

Secorapamycin B (Cat No.:C001129) is a macrocyclic polyketide antibiotic, a derivative of rapamycin. It exhibits promising antibacterial activity against certain Gram-positive bacteria, making it valuable in pharmaceutical research. This compound shows potential as an antibacterial agent for combating bacterial infections, and its structural similarities to rapamycin have sparked interest in its applications.


Catalog Number C001129
CAS Number 185107-79-3
Synonyms

[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-2-piperidinecarboxylic Acid; 34-Hydroxy Sirolimus; 34-Hydroxy Rapamycin

Molecular Formula C₅₁H₈₁NO₁₄
Purity ≥95%
Solubility Chloroform (Slightly), Methanol (Slightly)
Appearance White to Off-White Solid
Storage -20°C, Hygroscopic
IUPAC Name (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-dihydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15-tetraenyl]-2-hydroxy-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-carboxylic acid
InChI InChI=1S/C51H81NO14/c1-30(24-34(5)45(56)47(65-10)46(57)35(6)25-32(3)41(54)29-42(55)33(4)26-37-20-22-40(53)44(27-37)64-9)16-12-11-13-17-31(2)43(63-8)28-38-21-19-36(7)51(62,66-38)48(58)49(59)52-23-15-14-18-39(52)50(60)61/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,55,57,62H,14-15,18-24,26-29H2,1-10H3,(H,60,61)/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1
InChIKey HAZKEXYMOCBCBG-HPLJOQBZSA-N
SMILES CC1CCC(OC1(C(=O)C(=O)N2CCCCC2C(=O)O)O)CC(C(=CC=CC=CC(C)CC(C)C(=O)C(C(C(=CC(C)C(=O)CC(C(C)CC3CCC(C(C3)OC)O)O)C)O)OC)C)OC
Reference

Martel, P.R., et al.: Can. J. Physiol. Pharmacol., 55, 48 (1977), Carlson, R.P., et al.: J. Pharmacol. Exp. Ther., 266, 1125 (1993), Kahan, B.D., et al.: Lancet, 356, 194 (2000), Holmes, D.R., et al.: Circulation, 109, 634 (2004),

Request a Quote